Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today
announced results for the second quarter ended June 30, 2023.
Second Quarter Highlights
- Second quarter 2023 net revenue
declined 39.5% to $35.3 million, compared to $58.3 million in the
second quarter of 2022.
- Second quarter 2023 gross margin
declined to 42.2%, compared to 53.8% in the second quarter of 2022,
primarily reflecting the impact of our strategy of liquidating
high-cost inventory.
- Second quarter 2023 contribution
margin declined to (3.6)% from 9.7% in the second quarter of 2022,
primarily reflecting consumer softness and higher competitive
pricing pressure in cooling and air quality product categories and
an increased inventory obsolescence reserve.
- Second quarter 2023 operating loss
of ($36.4) million increased compared to a loss of ($10.1) million
in the second quarter of 2022. Second quarter 2023 operating loss
includes ($3.2) million of non-cash stock compensation, a non-cash
loss on impairment of intangibles of ($22.8) million, and
restructuring costs of $(1.2) million, while second quarter 2022
operating loss included a gain of $1.7 million from the change in
fair value of earn-out liabilities and ($6.0) million of non-cash
stock compensation.
- Second quarter 2023 net loss of
($34.8) million increased from ($6.3) million loss in the second
quarter of 2022. Second quarter 2023 net loss includes ($3.2)
million of non-cash stock compensation, a non-cash loss on
impairment of intangibles of ($22.8) million, restructuring costs
of ($1.2) million, and a gain on fair value of warrant liability of
$2.2 million, while second quarter 2022 net loss included ($6.0)
million in net charges from the changes in fair value of warrants,
($6.0) million of non-cash stock compensation and a gain of $1.7
million from the net change in fair value of earn-out
liabilities.
- Second quarter 2023 adjusted EBITDA
loss of ($8.0) million increased from ($3.7) million in the second
quarter of 2022.
- Total cash balance at June 30, 2023
was $28.9 million.
Third Quarter 2023 Outlook
For the third quarter, taking into account the
current global environment and inflation, we believe that net
revenue will be between $32.5 million and $37.5 million and expect
an adjusted EBITDA loss of between ($4.5) million to ($5.5)
million.
The Company’s third quarter 2023 guidance is
based on a number of assumptions that are subject to change, many
of which are outside the Company’s control. If actual results vary
from these assumptions, the Company’s expectations may change.
There can be no assurance that the Company will achieve these
results.
Non-GAAP Financial Measures
For more information on our non-GAAP financial
measures and a reconciliation of GAAP to non-GAAP measures, please
see the “Non-GAAP Financial Measures” section below. The most
directly comparable GAAP financial measure for EBITDA and adjusted
EBITDA is net loss and we expect to report a net loss for the three
months ending September 30, 2023, due primarily to our operating
losses, which includes stock-based compensation expense, and
interest expense. We are unable to reconcile the forward-looking
statements of EBITDA and adjusted EBITDA in this press release to
their nearest GAAP measures because the nearest GAAP financial
measures are not accessible on a forward-looking basis and
reconciling information is not available without unreasonable
effort.
Webcast and Conference Call
Information
Aterian will host a live conference call to
discuss financial results today, August 8, 2023, at 5:00 p.m.
Eastern Time, which will be accessible by telephone and the
internet. To access the call, participants from within the U.S.
should dial (833) 636-1351 and participants from outside the U.S.
should dial (412) 902-4267 and ask to be joined into the Aterian,
Inc. call. Participants may also access the call through a live
webcast at https://ir.aterian.io. The archived online replay will
be available for a limited time after the call in the Investors
Relations section of the Aterian website.
About Aterian, Inc.
Aterian, Inc. (Nasdaq: ATER) is a leading
technology-enabled consumer product company that builds, acquires,
and partners with leading e-commerce brands by harnessing
proprietary software and an agile supply chain to create top
selling consumer products. The Company’s cloud-based platform,
Artificial Intelligence Marketplace Ecommerce Engine (AIMEE™),
leverages machine learning, natural language processing and data
analytics to streamline the management of products at scale across
the world's largest online marketplaces with a focus on Amazon,
Shopify and Walmart. Aterian owns and operates a number of brands
and sells its products in multiple categories, including home and
kitchen appliances, health and wellness, beauty and consumer
electronics.
Forward Looking Statements
All statements other than statements of
historical facts included in this press release that address
activities, events or developments that we expect, believe or
anticipate will or may occur in the future are forward-looking
statements including, in particular, the statements regarding our
projected third quarter revenue and adjusted EBITDA, the current
global environment and inflation. These forward-looking statements
are based on management’s current expectations and beliefs and are
subject to a number of risks and uncertainties and other factors,
all of which are difficult to predict and many of which are beyond
our control and could cause actual results to differ materially and
adversely from those described in the forward-looking statements.
These risks include, but are not limited to, those related to our
ability to continue as a going concern, our ability to meet
financial covenants with our lenders, our ability to create
operating leverage and efficiency when integrating companies that
we acquire, including through the use of our team’s expertise, the
economies of scale of our supply chain and automation driven by our
platform; those related to our ability to grow internationally and
through the launch of products under our brands and the acquisition
of additional brands; those related to consumer demand, our cash
flows, financial condition, forecasting and revenue growth rate;
our supply chain including sourcing, manufacturing, warehousing and
fulfillment; our ability to manage expenses, working capital and
capital expenditures efficiently; our business model and our
technology platform; our ability to disrupt the consumer products
industry; our ability to maintain and to grow market share in
existing and new product categories; our ability to continue to
profitably sell the SKUs we operate; our ability to generate
profitability and stockholder value; international tariffs and
trade measures; inventory management, product liability claims,
recalls or other safety and regulatory concerns; reliance on third
party online marketplaces; seasonal and quarterly variations in our
revenue; acquisitions of other companies and technologies and our
ability to integrate such companies and technologies with our
business; our ability to continue to access debt and equity capital
(including on terms advantageous to the Company) and the extent of
our leverage; and other factors discussed in the “Risk Factors”
section of our most recent periodic reports filed with the
Securities and Exchange Commission (“SEC”), all of which you may
obtain for free on the SEC’s website at www.sec.gov.
Although we believe that the expectations
reflected in our forward-looking statements are reasonable, we do
not know whether our expectations will prove correct. You are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof, even if
subsequently made available by us on our website or otherwise. We
do not undertake any obligation to update, amend or clarify these
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under
applicable securities laws.
|
|
ATERIAN, INC. |
Consolidated Balance Sheets |
(in thousands, except share and per share
data) |
|
|
|
December 31,2022 |
|
June 30,2023 |
ASSETS |
|
|
|
|
Current assets: |
|
|
|
|
Cash |
|
$ |
43,574 |
|
|
$ |
28,867 |
|
Accounts receivable, net |
|
|
4,515 |
|
|
|
4,782 |
|
Inventory |
|
|
43,666 |
|
|
|
36,683 |
|
Prepaid and other current
assets |
|
|
8,261 |
|
|
|
5,326 |
|
Total current assets |
|
|
100,016 |
|
|
|
75,658 |
|
Property and equipment, net |
|
|
853 |
|
|
|
839 |
|
Other intangibles, net |
|
|
54,757 |
|
|
|
12,429 |
|
Other non-current assets |
|
|
813 |
|
|
|
543 |
|
Total assets |
|
$ |
156,439 |
|
|
$ |
89,469 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
Current Liabilities: |
|
|
|
|
Credit facility |
|
$ |
21,053 |
|
|
$ |
15,748 |
|
Accounts payable |
|
|
16,035 |
|
|
|
11,821 |
|
Seller notes |
|
|
1,693 |
|
|
|
1,206 |
|
Accrued and other current
liabilities |
|
|
14,254 |
|
|
|
11,978 |
|
Total current liabilities |
|
|
53,035 |
|
|
|
40,753 |
|
Other liabilities |
|
|
1,452 |
|
|
|
1,556 |
|
Total liabilities |
|
|
54,487 |
|
|
|
42,309 |
|
Commitments and contingencies
(Note 9) |
|
|
|
|
Stockholders' equity: |
|
|
|
|
Common stock, $0.0001 par value,
500,000,000 shares authorized and 80,752,290 and 88,014,844 shares
outstanding at December 31, 2022 and June 30, 2023,
respectively |
|
|
8 |
|
|
|
9 |
|
Additional paid-in capital |
|
|
728,339 |
|
|
|
733,878 |
|
Accumulated deficit |
|
|
(625,251 |
) |
|
|
(685,838 |
) |
Accumulated other comprehensive
loss |
|
|
(1,144 |
) |
|
|
(889 |
) |
Total stockholders’ equity |
|
|
101,952 |
|
|
|
47,160 |
|
Total liabilities and
stockholders' equity |
|
$ |
156,439 |
|
|
$ |
89,469 |
|
|
ATERIAN, INC. |
Consolidated Statements of Operations |
(in thousands, except share and per share
data) |
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
Net revenue |
|
$ |
58,268 |
|
|
$ |
35,264 |
|
|
$ |
99,941 |
|
|
$ |
70,143 |
|
Cost of good sold |
|
|
26,917 |
|
|
|
20,368 |
|
|
|
44,982 |
|
|
|
36,151 |
|
Gross profit |
|
|
31,351 |
|
|
|
14,896 |
|
|
|
54,959 |
|
|
|
33,992 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
Sales and distribution |
|
|
31,866 |
|
|
|
20,557 |
|
|
|
54,840 |
|
|
|
40,783 |
|
Research and development |
|
|
1,730 |
|
|
|
1,709 |
|
|
|
2,877 |
|
|
|
2,956 |
|
General and administrative |
|
|
9,571 |
|
|
|
6,281 |
|
|
|
19,112 |
|
|
|
12,240 |
|
Impairment loss on goodwill |
|
|
— |
|
|
|
— |
|
|
|
29,020 |
|
|
|
— |
|
Impairment loss on
intangibles |
|
|
— |
|
|
|
22,785 |
|
|
|
— |
|
|
|
39,445 |
|
Change in fair value of
contingent earn-out liabilities |
|
|
(1,691 |
) |
|
|
— |
|
|
|
(4,466 |
) |
|
|
— |
|
Total operating expenses |
|
|
41,476 |
|
|
|
51,332 |
|
|
|
101,383 |
|
|
|
95,424 |
|
Operating loss |
|
|
(10,125 |
) |
|
|
(36,436 |
) |
|
|
(46,424 |
) |
|
|
(61,432 |
) |
Interest expense, net |
|
|
338 |
|
|
|
346 |
|
|
|
1,138 |
|
|
|
717 |
|
Gain on extinguishment of seller
note |
|
|
— |
|
|
|
— |
|
|
|
(2,012 |
) |
|
|
— |
|
Loss on initial issuance of
equity |
|
|
— |
|
|
|
— |
|
|
|
5,835 |
|
|
|
— |
|
Change in fair value of warrant
liability |
|
|
6,014 |
|
|
|
(2,197 |
) |
|
|
7,893 |
|
|
|
(1,843 |
) |
Other (income) expense, net |
|
|
— |
|
|
|
176 |
|
|
|
(25 |
) |
|
|
229 |
|
Loss before income taxes |
|
|
(16,477 |
) |
|
|
(34,761 |
) |
|
|
(59,253 |
) |
|
|
(60,535 |
) |
Provision (benefit) for income
taxes |
|
|
(168 |
) |
|
|
26 |
|
|
|
(168 |
) |
|
|
52 |
|
Net loss |
|
$ |
(16,309 |
) |
|
$ |
(34,787 |
) |
|
$ |
(59,085 |
) |
|
$ |
(60,587 |
) |
Net loss per share, basic and
diluted |
|
$ |
(0.26 |
) |
|
$ |
(0.45 |
) |
|
$ |
(0.94 |
) |
|
$ |
(0.78 |
) |
Weighted-average number of shares
outstanding, basic and diluted |
|
|
63,947,069 |
|
|
|
77,625,304 |
|
|
|
62,749,520 |
|
|
|
77,181,388 |
|
|
ATERIAN, INC. |
Consolidated Statements of Cash Flows |
(in thousands) |
|
|
|
Six Months Ended June 30, |
|
|
|
2022 |
|
|
|
2023 |
|
OPERATING ACTIVITIES: |
|
|
|
|
Net loss |
|
$ |
(59,085 |
) |
|
$ |
(60,587 |
) |
Adjustments to reconcile net loss
to net cash used by operating activities: |
|
|
|
|
Depreciation and
amortization |
|
|
3,894 |
|
|
|
2,964 |
|
Provision for sales returns |
|
|
226 |
|
|
|
(170 |
) |
Amortization of deferred
financing cost and debt discounts |
|
|
213 |
|
|
|
213 |
|
Stock-based compensation |
|
|
8,913 |
|
|
|
5,539 |
|
Gain from decrease of contingent
earn-out liability fair value |
|
|
(4,466 |
) |
|
|
— |
|
Change in inventory
provisions |
|
|
— |
|
|
|
262 |
|
Loss in connection with the
change in warrant fair value |
|
|
7,893 |
|
|
|
(1,843 |
) |
Gain in connection with
settlement of note payable |
|
|
(2,012 |
) |
|
|
— |
|
Loss on initial issuance of
equity |
|
|
5,835 |
|
|
|
— |
|
Impairment loss on goodwill |
|
|
29,020 |
|
|
|
— |
|
Impairment loss on
intangibles |
|
|
— |
|
|
|
39,445 |
|
Allowance for doubtful accounts
and other |
|
|
127 |
|
|
|
— |
|
Changes in assets and
liabilities: |
|
|
|
|
Accounts receivable |
|
|
3,304 |
|
|
|
(267 |
) |
Inventory |
|
|
(13,071 |
) |
|
|
6,721 |
|
Prepaid and other current
assets |
|
|
2,108 |
|
|
|
2,469 |
|
Accounts payable, accrued and
other liabilities |
|
|
(5,010 |
) |
|
|
(3,603 |
) |
Cash used in operating
activities |
|
|
(22,111 |
) |
|
|
(8,857 |
) |
INVESTING ACTIVITIES: |
|
|
|
|
Purchase of fixed assets |
|
|
(16 |
) |
|
|
(66 |
) |
Purchase of Step and Go
assets |
|
|
— |
|
|
|
(125 |
) |
Cash used in investing
activities |
|
|
(16 |
) |
|
|
(191 |
) |
FINANCING ACTIVITIES: |
|
|
|
|
Proceeds from equity offering,
net of issuance costs |
|
|
27,007 |
|
|
|
— |
|
Repayments on note payable to
Smash |
|
|
(1,778 |
) |
|
|
(501 |
) |
Payment of Squatty Potty
earn-out |
|
|
(3,983 |
) |
|
|
— |
|
Borrowings from MidCap credit
facilities |
|
|
71,914 |
|
|
|
38,060 |
|
Repayments for MidCap credit
facilities |
|
|
(70,972 |
) |
|
|
(43,572 |
) |
Insurance obligation
payments |
|
|
(719 |
) |
|
|
(534 |
) |
Cash provided (used) by financing
activities |
|
|
21,469 |
|
|
|
(6,547 |
) |
Foreign currency effect on cash,
cash equivalents, and restricted cash |
|
|
(602 |
) |
|
|
255 |
|
Net change in cash and restricted
cash for the year |
|
|
(1,260 |
) |
|
|
(15,340 |
) |
Cash and restricted cash at
beginning of year |
|
|
38,315 |
|
|
|
46,629 |
|
Cash and restricted cash at end
of year |
|
$ |
37,055 |
|
|
$ |
31,289 |
|
RECONCILIATION OF CASH AND
RESTRICTED CASH: |
|
|
|
|
Cash |
|
|
34,781 |
|
|
|
28,867 |
|
Restricted Cash—Prepaid and other
current assets |
|
|
2,145 |
|
|
|
2,293 |
|
Restricted cash—Other non-current
assets |
|
|
129 |
|
|
|
129 |
|
TOTAL CASH AND RESTRICTED
CASH |
|
$ |
37,055 |
|
|
$ |
31,289 |
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURES OF CASH
FLOW INFORMATION |
|
|
|
|
Cash paid for interest |
|
$ |
828 |
|
|
$ |
1,038 |
|
Cash paid for taxes |
|
$ |
58 |
|
|
$ |
80 |
|
NON-CASH INVESTING AND FINANCING
ACTIVITIES: |
|
|
|
|
Non-cash consideration paid to
contractors |
|
$ |
1,137 |
|
|
$ |
321 |
|
Fair value of warrants issued in
connection with equity offering |
|
$ |
18,982 |
|
|
$ |
— |
|
Issuance of common stock related
to exercise of warrants |
|
$ |
767 |
|
|
$ |
— |
|
Exercise of prefunded
warrants |
|
$ |
15,039 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures
We believe that our financial statements and the
other financial data included in this Quarterly Report have been
prepared in a manner that complies, in all material respects, with
generally accepted accounting principles in the U.S. (“GAAP”).
However, for the reasons discussed below, we have presented certain
non-GAAP measures herein.
We have presented the following non-GAAP
measures to assist investors in understanding our core net
operating results on an on-going basis: (i) Contribution Margin;
(ii) Contribution margin as a percentage of net revenue; (iii)
EBITDA (iv) Adjusted EBITDA; and (v) Adjusted EBITDA as a
percentage of net revenue. These non-GAAP financial measures may
also assist investors in making comparisons of our core operating
results with those of other companies.
As used herein, Contribution margin represents
gross profit less e-commerce platform commissions, online
advertising, selling and logistics expenses (included in sales and
distribution expenses). As used herein, Contribution margin as a
percentage of net revenue represents Contribution margin divided by
net revenue. As used herein, EBITDA represents net loss plus
depreciation and amortization, interest expense, net and provision
for income taxes. As used herein, Adjusted EBITDA represents EBITDA
plus stock-based compensation expense, changes in fair-market value
of earn-outs, profit and loss impacts from the issuance of common
stock and/or warrants, changes in fair-market value of warrant
liability, litigation settlements, impairment on goodwill and
intangibles, gain from extinguishment of debt, restructuring
expenses and other expenses, net. As used herein, Adjusted EBITDA
as a percentage of net revenue represents Adjusted EBITDA divided
by net revenue. Contribution margin, EBITDA and Adjusted EBITDA do
not represent and should not be considered as alternatives to loss
from operations or net loss, as determined under GAAP.
We present Contribution margin and Contribution
margin as a percentage of net revenue, as we believe each of these
measures provides an additional metric to evaluate our operations
and, when considered with both our GAAP results and the
reconciliation to gross profit, provides useful supplemental
information for investors. Specifically, Contribution margin and
Contribution margin as a Non-GAAP Financial Measure percentage of
net revenue are two of our key metrics in running our business. All
product decisions made by us, from the approval of launching a new
product and to the liquidation of a product at the end of its life
cycle, are measured primarily from Contribution margin and/or
Contribution margin as a percentage of net revenue. Further, we
believe these measures provide improved transparency to our
stockholders to determine the performance of our products prior to
fixed costs as opposed to referencing gross profit alone.
In the reconciliation to calculate contribution
margin, we add e-commerce platform commissions, online advertising,
selling and logistics expenses (“sales and distribution variable
expense”) to gross profit to inform users of our financial
statements of what our product profitability is at each period
prior to fixed costs (such as sales and distribution expenses such
as salaries as well as research and development expenses and
general administrative expenses). By excluding these fixed costs,
we believe this allows users of our financial statements to
understand our products performance and allows them to measure our
products performance over time.
We present EBITDA, Adjusted EBITDA and Adjusted
EBITDA as a percentage of net revenue because we believe each of
these measures provides an additional metric to evaluate our
operations and, when considered with both our GAAP results and the
reconciliation to net loss, provide useful supplemental information
for investors. We use these measures with financial measures
prepared in accordance with GAAP, such as sales and gross margins,
to assess our historical and prospective operating performance, to
provide meaningful comparisons of operating performance across
periods, to enhance our understanding of our operating performance
and to compare our performance to that of our peers and
competitors. We believe EBITDA, Adjusted EBITDA and Adjusted EBITDA
as a percentage of net revenue are useful to investors in assessing
the operating performance of our business without the effect of
non-cash items.
Contribution margin, Contribution margin as a
percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted
EBITDA as a percentage of net revenue should not be considered in
isolation or as alternatives to net loss, loss from operations or
any other measure of financial performance calculated and
prescribed in accordance with GAAP. Neither EBITDA, Adjusted EBITDA
or Adjusted EBITDA as a percentage of net revenue should be
considered a measure of discretionary cash available to us to
invest in the growth of our business. Our Contribution margin,
Contribution margin as a percentage of net revenue, EBITDA,
Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue
may not be comparable to similar titled measures in other
organizations because other organizations may not calculate
Contribution margin, Contribution margin as a percentage of net
revenue, EBITDA, Adjusted EBITDA or Adjusted EBITDA as a percentage
of net revenue in the same manner as we do. Our presentation of
Contribution margin and Adjusted EBITDA should not be construed as
an inference that our future results will be unaffected by the
expenses that are excluded from such terms or by unusual or
non-recurring items.
We recognize that EBITDA, Adjusted EBITDA and
Adjusted EBITDA as a percentage of net revenue, have limitations as
analytical financial measures. For example, neither EBITDA nor
Adjusted EBITDA reflects:
• our capital expenditures or future
requirements for capital expenditures or mergers and
acquisitions;
• the interest expense or the cash requirements
necessary to service interest expense or principal payments,
associated with indebtedness;
• depreciation and amortization, which are
non-cash charges, although the assets being depreciated and
amortized will likely have to be replaced in the future, or any
cash requirements for the replacement of assets;
• changes in cash requirements for our working
capital needs; or
• changes in fair value of contingent earn-out
liabilities, warrant liabilities, and amortization of inventory
step-up from acquisitions (included in cost of goods sold).
Additionally, Adjusted EBITDA excludes non-cash
expense for stock-based compensation, which is and is expected to
remain a key element of our overall long-term incentive
compensation package.
We also recognize that Contribution margin and
Contribution margin as a percentage of net revenue have limitations
as analytical financial measures. For example, Contribution margin
does not reflect:
• general and administrative expense necessary
to operate our business; •research and development expenses
necessary for the development, operation and support of our
software platform;
• the fixed costs portion of our sales and
distribution expenses including stock-based compensation expense;
or
• changes in fair value of contingent earn-out
liabilities, warrant liabilities, and amortization of inventory
step-up from acquisitions (included in cost of goods sold).
Contribution Margin
The following table provides a reconciliation of
Contribution margin to gross profit and Contribution margin as a
percentage of net revenue to gross profit as a percentage of net
revenue, which are the most directly comparable financial measures
presented in accordance with GAAP:
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
(in thousands, except percentages) |
|
Gross Profit |
$ |
31,351 |
|
|
$ |
14,896 |
|
|
$ |
54,959 |
|
|
$ |
33,992 |
|
|
Less: |
|
|
|
|
|
|
|
|
E-commerce platform commissions,
online advertising, selling and logistics expenses |
|
(25,703 |
) |
|
|
(16,164 |
) |
|
|
(45,479 |
) |
|
|
(33,193 |
) |
|
Contribution margin |
$ |
5,648 |
|
|
$ |
(1,268 |
) |
|
$ |
9,480 |
|
|
$ |
799 |
|
|
Gross Profit as a percentage of
net revenue |
|
53.8 |
% |
|
|
42.2 |
% |
|
|
55.0 |
% |
|
|
48.5 |
% |
|
Contribution margin as a
percentage of net revenue |
|
9.7 |
% |
|
|
(3.6 |
)% |
|
|
9.5 |
% |
|
|
1.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
The following table provides a reconciliation of
EBITDA and Adjusted EBITDA to net loss, which is the most directly
comparable financial measure presented in accordance with GAAP:
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
(in thousands, except percentages) |
|
Net loss |
$ |
(16,309 |
) |
|
$ |
(34,787 |
) |
|
$ |
(59,085 |
) |
|
$ |
(60,587 |
) |
|
Add: |
|
|
|
|
|
|
|
|
Provision (benefit) for income
taxes |
|
(168 |
) |
|
|
26 |
|
|
|
(168 |
) |
|
|
52 |
|
|
Interest expense, net |
|
338 |
|
|
|
346 |
|
|
|
1,138 |
|
|
|
717 |
|
|
Depreciation and
amortization |
|
2,048 |
|
|
|
1,202 |
|
|
|
3,894 |
|
|
|
2,964 |
|
|
EBITDA |
|
(14,091 |
) |
|
|
(33,213 |
) |
|
|
(54,221 |
) |
|
|
(56,854 |
) |
|
Other (income) expense, net |
|
— |
|
|
|
176 |
|
|
|
(25 |
) |
|
|
229 |
|
|
Change in fair value of
contingent earn-out liabilities |
|
(1,691 |
) |
|
|
— |
|
|
|
(4,466 |
) |
|
|
— |
|
|
Impairment loss on goodwill |
|
— |
|
|
|
— |
|
|
|
29,020 |
|
|
|
— |
|
|
Impairment loss on
intangibles |
|
— |
|
|
|
22,785 |
|
|
|
— |
|
|
|
39,445 |
|
|
Gain on extinguishment of seller
note |
|
— |
|
|
|
— |
|
|
|
(2,012 |
) |
|
|
— |
|
|
Change in fair market value of
warrant liability |
|
6,014 |
|
|
|
(2,197 |
) |
|
|
7,893 |
|
|
|
(1,843 |
) |
|
Loss on original issuance of
equity |
|
— |
|
|
|
— |
|
|
|
5,835 |
|
|
|
— |
|
|
Litigation reserve |
|
— |
|
|
|
— |
|
|
|
800 |
|
|
|
— |
|
|
Restructuring expense |
|
— |
|
|
|
1,216 |
|
|
|
— |
|
|
|
1,216 |
|
|
Stock-based compensation
expense |
|
6,048 |
|
|
|
3,223 |
|
|
|
8,913 |
|
|
|
5,539 |
|
|
Adjusted EBITDA |
$ |
(3,720 |
) |
|
$ |
(8,010 |
) |
|
$ |
(8,263 |
) |
|
$ |
(12,268 |
) |
|
Net loss as a percentage of net
revenue |
|
(28.0 |
)% |
|
|
(98.6 |
)% |
|
|
(59.1 |
)% |
|
|
(86.4 |
)% |
|
Adjusted EBITDA as a percentage
of net revenue |
|
(6.4 |
)% |
|
|
(22.7 |
)% |
|
|
(8.3 |
)% |
|
|
(17.5 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Each of our products typically goes through the
Launch phase and depending on its level of success is moved to one
of the other phases as further described below:
i. Launch phase: During this phase,
we leverage our technology to target opportunities identified using
AIMEE (Artificial Intelligence Marketplace e-Commerce Engine) and
other sources. This phase also includes revenue from new product
variations and relaunches. During this period of time, due to the
combination of discounts and investment in marketing, our net
margin for a product could be as low as approximately negative 35%.
Net margin is calculated by taking net revenue less the cost of
goods sold, less fulfillment, online advertising and selling
expenses. These primarily reflect the estimated variable costs
related to the sale of a product.
ii. Sustain phase: Our goal is for
every product we launch to enter the sustain phase and become
profitable, with a target of positive 15% net margin for most
products, within approximately three months of launch on average.
Net margin primarily reflects a combination of manual and automated
adjustments in price and marketing spend.
iii. Liquidate phase: If a product does
not enter the sustain phase or if the customer satisfaction of the
product (i.e., ratings) is not satisfactory, then it will go to the
liquidate phase and we will sell through the remaining inventory.
Products can also be liquidated as part of inventory normalization
especially when steep discounts are required.
The following tables break out our second
quarter of 2022 and 2023 results of operations by our product
phases (in thousands):
|
|
Three months ended June 30, 2022 |
|
|
Sustain |
|
Launch |
|
Liquidation/ Other |
|
Fixed Costs |
|
Stock Based Compensation |
|
Total |
Net revenue |
|
$ |
54,080 |
|
$ |
1,342 |
|
$ |
2,846 |
|
$ |
— |
|
|
$ |
— |
|
$ |
58,268 |
|
Cost of goods sold |
|
|
24,259 |
|
|
742 |
|
|
1,916 |
|
|
— |
|
|
|
— |
|
|
26,917 |
|
Gross profit |
|
|
29,821 |
|
|
600 |
|
|
930 |
|
|
— |
|
|
|
— |
|
|
31,351 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution
expenses |
|
|
22,635 |
|
|
632 |
|
|
2,435 |
|
|
3,281 |
|
|
|
2,883 |
|
|
31,866 |
|
Research and development |
|
|
— |
|
|
— |
|
|
— |
|
|
1,097 |
|
|
|
633 |
|
|
1,730 |
|
General and
administrative |
|
|
— |
|
|
— |
|
|
— |
|
|
7,038 |
|
|
|
2,533 |
|
|
9,571 |
|
Change in earn-out
liability |
|
|
— |
|
|
— |
|
|
— |
|
|
(1,691 |
) |
|
|
— |
|
|
(1,691 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30,
2023 |
|
|
Sustain |
|
Launch |
|
Liquidation/ Other |
|
Fixed Costs |
|
Stock Based Compensation |
|
Total |
Net revenue |
|
$ |
30,985 |
|
$ |
42 |
|
$ |
4,237 |
|
$ |
— |
|
|
$ |
— |
|
$ |
35,264 |
|
Cost of goods sold |
|
|
16,505 |
|
|
20 |
|
|
3,843 |
|
|
— |
|
|
|
— |
|
|
20,368 |
|
Gross profit |
|
|
14,480 |
|
|
22 |
|
|
394 |
|
|
— |
|
|
|
— |
|
|
14,896 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution
expenses |
|
|
13,841 |
|
|
33 |
|
|
2,290 |
|
|
3,302 |
|
|
|
1,091 |
|
|
20,557 |
|
Research and development |
|
|
— |
|
|
— |
|
|
— |
|
|
1,286 |
|
|
|
423 |
|
|
1,709 |
|
General and
administrative |
|
|
— |
|
|
— |
|
|
— |
|
|
4,572 |
|
|
|
1,709 |
|
|
6,281 |
|
Impairment loss on
intangibles |
|
|
— |
|
|
— |
|
|
— |
|
|
22,785 |
|
|
|
— |
|
|
22,785 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30,
2022 |
|
|
Sustain |
|
Launch |
|
Liquidation/Other |
|
Fixed Costs |
|
Stock BasedCompensation |
|
Total |
Net revenue |
|
$ |
92,044 |
|
$ |
2,179 |
|
$ |
5,718 |
|
$ |
— |
|
|
$ |
— |
|
$ |
99,941 |
|
Cost of goods sold |
|
|
40,008 |
|
|
1,153 |
|
|
3,821 |
|
|
— |
|
|
|
— |
|
|
44,982 |
|
Gross profit |
|
|
52,036 |
|
|
1,026 |
|
|
1,897 |
|
|
— |
|
|
|
— |
|
|
54,959 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution
expenses |
|
|
40,114 |
|
|
1,167 |
|
|
4,197 |
|
|
6,133 |
|
|
|
3,229 |
|
|
54,840 |
|
Research and development |
|
|
— |
|
|
— |
|
|
— |
|
|
1,970 |
|
|
|
907 |
|
|
2,877 |
|
General and
administrative |
|
|
— |
|
|
— |
|
|
— |
|
|
14,335 |
|
|
|
4,777 |
|
|
19,112 |
|
Impairment loss on
goodwill |
|
|
— |
|
|
— |
|
|
— |
|
|
29,020 |
|
|
|
— |
|
|
29,020 |
|
Change in earn-out
liability |
|
|
— |
|
|
— |
|
|
— |
|
|
(4,466 |
) |
|
|
— |
|
|
(4,466 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2023 |
|
|
Sustain |
|
Launch |
|
Liquidation/Other |
|
Fixed Costs |
|
Stock BasedCompensation |
|
Total |
Net revenue |
|
$ |
59,616 |
|
$ |
200 |
|
$ |
10,327 |
|
$ |
— |
|
|
$ |
— |
|
$ |
70,143 |
|
Cost of goods sold |
|
|
28,183 |
|
|
111 |
|
|
7,857 |
|
|
— |
|
|
|
— |
|
|
36,151 |
|
Gross profit |
|
|
31,433 |
|
|
89 |
|
|
2,470 |
|
|
— |
|
|
|
— |
|
|
33,992 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution
expenses |
|
|
27,194 |
|
|
152 |
|
|
5,847 |
|
|
5,829 |
|
|
|
1,761 |
|
|
40,783 |
|
Research and development |
|
|
— |
|
|
— |
|
|
— |
|
|
2,099 |
|
|
|
857 |
|
|
2,956 |
|
General and
administrative |
|
|
— |
|
|
— |
|
|
— |
|
|
9,319 |
|
|
|
2,921 |
|
|
12,240 |
|
Impairment loss on
intangibles |
|
|
— |
|
|
— |
|
|
— |
|
|
39,445 |
|
|
|
— |
|
|
39,445 |
|
Investor Contact:
Ilya Grozovsky
Director of Investor Relations & Corp. Development
Aterian, Inc.
ilya@aterian.io
917-905-1699
aterian.io
Aterian (NASDAQ:ATER)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Aterian (NASDAQ:ATER)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025